Scilex Holding (SCLX) shares rose 4.3% in recent Wednesday trading after Denali Capital Acquisition (DECA) filed a registration statement on Form S-4 related to the proposed business combination between Denali and Scilex's Semnur Pharmaceuticals unit.

The previously announced merger provides for a pre-transaction equity value of Semnur of $2.5 billion and is anticipated to close in Q1 next year, Semnur said.

Price: 1.10, Change: +0.04, Percent Change: +4.29